Andres is the member of the board of CELVIA and a professor of reproductive medicine at the University of Tartu and the Swedish Karolinska Institute. He obtained his doctorate at the University of Helsinki. Andres is one of the leading reproductive medicine researchers in the Baltics and Scandinavia. As an active researcher, he has published over 200 articles and actively participates in several international collaborations.

Alberto is researcher at CELVIA and Karolinska Institutet. He completed his PhD at the University of Granada (Spain), where he investigated the role of microbes in female reproduction. His current research focuses on the use of advanced in vitro models and multi-omics techniques to unravel potential factors that can influence embryo implantation. Coordinator of the Special Interest Group in Reproductive Genetics at ESHRE.

Dr Amruta Pathare is a Senior Researcher at Karolinska Institutet, Sweden, and a Co-Principal Investigator at Celvia CC AS, Estonia. Her research focuses on endometrial biology, embryo implantation, reproductive disorders, and the molecular mechanisms affecting fertility and pregnancy outcomes. Her work integrates transcriptomics, single-cell analysis, functional genomics, organoid and embryo–endometrium models, and computational approaches to study reproductive health.

Barış Yaşar received his Bachelor of Science (B.Sc.) degree in Molecular Biology and Genetics from Bilkent University, Ankara, Turkey, in 2014. He then joined the Molecular Biosciences degree programme at Heidelberg University, Germany, where he received his Master of Science (M.Sc.) degree in 2017 and continued to work as a Research Assistant. In 2020, he began his doctoral studies through a joint Ph.D. programme between the University of Tartu and Karolinska Institutet as part of the European Union’s Horizon 2020 Marie Skłodowska-Curie Actions. He received his doctoral degrees from the University of Tartu and Karolinska Institutet in 2026. His doctoral research focused on early embryo development and embryonic genome activation (EGA), using bovine embryos as a model organism. He combined molecular cloning, transcriptomic profiling, and computational and evolutionary analyses to characterize genes and regulatory elements involved in bovine EGA, particularly PRD-like homeobox transcription factors and their regulation during preimplantation development.

Nataliya Kotsabyn, MD, PhD is a gynecologist-reproductive specialist, ultrasound specialist and geneticist from Ukraine. President of the Ukrainian Hysteroscopy Association and head doctor of Medical Center of Human Reproduction “DAMIA” in Ivano-Frankivsk. She specializes in hysteroscopy, recurrent implantation failure (RIF), adenomyosis, and reproductive endocrinology. She organizes international training courses and conferences in hysteroscopy and ultrasound, including OPUS LAB programs.

Pol Solé-Navais is a group leader at the Wallenberg Laboratory, University of Gothenburg (Sweden), with extensive experience in international collaborative genetic efforts. By integrating computational biology with large-scale genetic and registry data, we aim to understand the mechanisms behind pregnancy loss and other pregnancy and neonatal outcomes. Our ultimate goal is to transform reproductive biology, advance molecular diagnostics and understand the fundamental mechanisms behind human development through the lens of genetic variation.

Prof. Ganesh Acharya, MD, PhD, FRCOG, is Head of the Division of Obstetrics & Gynaecology and Director of the Centre for Embryonic and Prenatal Precision Medicine at Karolinska Institutet, as well as Senior Consultant at the Centre for Fetal Medicine, Karolinska University Hospital in Stockholm. He trained in medicine and obstetrics and gynaecology across Ukraine, Nepal, the UK, Norway, and the USA, and holds additional qualifications in medical imaging, fetal medicine, and perinatal cardiology. With extensive international clinical and academic experience, he was appointed Professor at the University of Tromsø in 2008 and at Karolinska Institutet in 2016. He also served as Editor-in-Chief of Acta Obstetricia et Gynecologica Scandinavica from 2015 to 2025. His research spans obstetrics and gynaecology, with a particular focus on embryonic and fetal development, cardiovascular physiology, and prenatal medicine.

He holds a degree in Molecular Biology and Biochemistry from Universidad Autónoma de Madrid (1993) and a PhD from the same university (2000), where he conducted research in virology under Dr. Margarita Salas. He later served as Scientific Director of Fundación IVI and was a founder and CSO of iGenomix. Since 2011, he has combined academic and entrepreneurial activities, holding positions in Genetics at Pablo de Olavide University and Loyola University in Seville while founding several biotechnology and health-related companies, including Recombine Europe, iGLS, SINAE, Fullgenomics, Overture Life, and HoMu Health Ventures. His research focuses primarily on the molecular basis of endometrial receptivity and reproductive medicine, with around 60 scientific publications, six patents, and more than 15 books and book chapters. Throughout his career, he has worked at several leading universities and research institutions across Spain, Germany, the UK, Brazil, and the United States.